Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolus (EOLS) EBT (2017 - 2026)

Evolus filings provide 9 years of EBT readings, the most recent being -$10.4 million for Q1 2026.

  • On a quarterly basis, EBT rose 44.64% to -$10.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$42.6 million, a 23.33% increase, with the full-year FY2025 number at -$51.0 million, down 2.43% from a year prior.
  • EBT hit -$10.4 million in Q1 2026 for Evolus, down from $515000.0 in the prior quarter.
  • In the past five years, EBT ranged from a high of $515000.0 in Q4 2025 to a low of -$23.4 million in Q2 2022.
  • Median EBT over the past 5 years was -$15.6 million (2025), compared with a mean of -$14.5 million.
  • Biggest five-year swings in EBT: crashed 372.93% in 2022 and later skyrocketed 108.11% in 2025.
  • Evolus' EBT stood at -$13.1 million in 2022, then rose by 10.54% to -$11.7 million in 2023, then surged by 45.83% to -$6.4 million in 2024, then skyrocketed by 108.11% to $515000.0 in 2025, then crashed by 2122.91% to -$10.4 million in 2026.
  • The last three reported values for EBT were -$10.4 million (Q1 2026), $515000.0 (Q4 2025), and -$15.6 million (Q3 2025) per Business Quant data.